These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 30220923)
1. Cure in metastatic breast cancer. Westphal T; Gampenrieder SP; Rinnerthaler G; Greil R Memo; 2018; 11(3):172-179. PubMed ID: 30220923 [TBL] [Abstract][Full Text] [Related]
2. Oligometastatic Breast Cancer: How to Manage It? Barberi V; Pietragalla A; Franceschini G; Marazzi F; Paris I; Cognetti F; Masetti R; Scambia G; Fabi A J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207648 [TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
4. Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal? Sabanathan D; Park JJ; Marquez M; Francisco L; Byrne N; Gurney H Oncologist; 2017 Dec; 22(12):1470-1477. PubMed ID: 29146617 [TBL] [Abstract][Full Text] [Related]
5. Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer: A Review. Tarantino P; Curigliano G; Parsons HA; Lin NU; Krop I; Mittendorf EA; Waks A; Winer EP; Tolaney SM JAMA Oncol; 2022 Apr; 8(4):629-635. PubMed ID: 35024766 [TBL] [Abstract][Full Text] [Related]
6. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review. Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161 [TBL] [Abstract][Full Text] [Related]
7. Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure. Merloni F; Palleschi M; Casadei C; Romeo A; Curcio A; Casadei R; Stella F; Ercolani G; Gianni C; Sirico M; Cima S; Sarti S; Cecconetto L; Di Menna G; De Giorgi U Ther Adv Med Oncol; 2023; 15():17588359231161412. PubMed ID: 36950272 [TBL] [Abstract][Full Text] [Related]
8. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review. Kent CL; McDuff SGR; Salama JK Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069 [TBL] [Abstract][Full Text] [Related]
9. Role of Immunotherapy in Triple-Negative Breast Cancer. Keenan TE; Tolaney SM J Natl Compr Canc Netw; 2020 Apr; 18(4):479-489. PubMed ID: 32259782 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Survival and Cure in Distant Metastatic Breast Cancer. Güth U; Elfgen C; Montagna G; Schmid SM Oncology; 2019; 97(2):82-93. PubMed ID: 31055570 [TBL] [Abstract][Full Text] [Related]
11. Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option. Faehling M; Fallscheer S; Kramberg S; Sträter J; Eschmann S; Sätzler R; Heinzelmann F Eur J Cancer; 2021 Oct; 156():175-186. PubMed ID: 34461420 [TBL] [Abstract][Full Text] [Related]
12. Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Agostinetto E; Losurdo A; Nader-Marta G; Santoro A; Punie K; Barroso R; Popovic L; Solinas C; Kok M; de Azambuja E; Lambertini M Expert Opin Investig Drugs; 2022 Jun; 31(6):567-591. PubMed ID: 35240902 [TBL] [Abstract][Full Text] [Related]
13. Can we cure oligometastatic disease? A practical point of view. Pérez-García J; Cortez P; Gion M; Cortés J Curr Opin Oncol; 2020 Nov; 32(6):568-574. PubMed ID: 32925203 [TBL] [Abstract][Full Text] [Related]
14. Role of radiotherapy in oligometastatic breast cancer: Review of the literature. Beduk Esen CS; Gultekin M; Yildiz F World J Clin Oncol; 2022 Jan; 13(1):39-48. PubMed ID: 35116231 [TBL] [Abstract][Full Text] [Related]
15. Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer. Peinado P; Ramírez C; García-Sáenz JA; Pascual A; Fuentes-Antrás J; Vidal N; Antoñanzas M; Moreno F Breast Care (Basel); 2020 Aug; 15(4):428-432. PubMed ID: 32982655 [TBL] [Abstract][Full Text] [Related]
16. Oligometastatic breast cancer: Are we there yet? AlSendi M; O'Reilly D; Zeidan YH; Kelly CM Int J Cancer; 2021 Oct; 149(8):1520-1528. PubMed ID: 34013530 [TBL] [Abstract][Full Text] [Related]
17. The Role of Cyclin-Dependent Kinase 4/6 Inhibitors Treatment in Oligometastatic Breast Cancer: A Case Report on a Possible Curative Intent Strategy. Valente A; Teixeira Tavares N; Caeiro C; Barbosa M; Augusto I Cureus; 2023 Feb; 15(2):e34893. PubMed ID: 36925985 [TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population. Jongbloed M; Bartolomeo V; Steens M; Dursun S; van de Lisdonk T; De Ruysscher DKM; Hendriks LEL Eur J Cancer; 2023 Sep; 190():112947. PubMed ID: 37451182 [TBL] [Abstract][Full Text] [Related]